Navigation Links
Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement For Plasmid DNA Production
Date:2/26/2013

ies, Inc.
Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services. Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Althea's formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. For more information, visit www.altheatech.com

About Profectus Biosciences.
Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of infectious diseases and related cancers, with the goal of reducing morbidity and mortality. Since its inception in 2003, the Company's strategic intent has been to acquire and develop the technologies needed to achieve this goal. The Company has licensed a group of vaccine?based technologies from Wyeth Vaccines (now Pfizer, Inc.) that greatly enhance the immunogenicity of prophylactic and therapeutic vaccines based on a "prime?boost" strategy. This strategy uses the delivery of a best?in?class pDNA vaccine to "prime" the immune system, followed by a first-in-class "boost" with an rVSV vector. Current disease and virus targets include hepatitis C virus (HCV), human papilloma virus (HPV), herpes simplex virus type 2 (HSV?2), human immunodeficiency virus (HIV), Ebola virus, Marburg Virus, the arenaviruses and malaria. The Profectus HIV DNA vaccine program has b
'/>"/>

SOURCE Althea Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. University of Colorado and Orphan Technologies sign agreement
2. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
3. LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology
4. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
5. New modeling approach transforms imaging technologies
6. Life Technologies ayudar√° a identificar 20.000 restos humanos encontrados en fosas comunes en Libia
7. New supercomputer coming to EMSL this summer, supplied by Atipa Technologies
8. UT Dallas researchers awarded $4.3 million to create next-generation technologies
9. ASU partners with Life Technologies on US DHHS funded project to rapidly assess radiation dose
10. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
11. NREL researchers use imaging technologies to solve puzzle of plant architecture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
(Date:7/9/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/98rrmr/biometrics_for ... "Biometrics for Banking; Market & Technology Analysis, Adoption ... offering. The adoption for banking purposes ... the forecast is that by 2020 it will ... in delivering biometric systems to the banking industry. ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... yielded a rapid, inexpensive way to make large numbers of ... from attacking the body. , The ability to easily make ... treatment and a better understanding of autoimmune diseases such as ... say. , T cells are components of the immune system ...
... of transcription, in which the enzyme RNA polymerase constructs ... upon previously underappreciated sections of both the DNA promoter ... the bacterium E. coli and published today (June 16) ... from the University of Wisconsin-Madison. , This fundamental ...
... second, the cells constituting our bodies are replaced through ... piece of the puzzle of how genetic information remains ... are presented in the latest issue of the scientific ... about 50,000 billion cells, 1% of which die and ...
Cached Biology News:Finding paves way for better treatment of autoimmune disease 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 3A protein complex that untangles DNA 2
(Date:7/28/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/z54c4k/biomedical ... "Biomedical Refrigerators and Freezers Market - Global Industry ... - 2022" report to their offering. ... market has been segmented based on applications: hospitals, ... others. The others segment includes applications of biomedical ...
(Date:7/28/2015)... N.J. , July 28, 2015  Moerae ... second Phase 1 clinical trial with MMI-0100, a ... is being developed for pulmonary disorders characterized by ... United Kingdom , is a ... further evaluating the safety and tolerability of MMI-0100 ...
(Date:7/28/2015)... ZIONA, Israel , July 28, ... OTC:CQPTY), a regenerative medicine company utilizing its proprietary ... announced that Shomrat Shurtz has been appointed Senior ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) ... years of experience in marketing, regulatory and business ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... the Biophotonics industry.The report provides a basic overview of the industry including definitions, ... the international markets including development trends, competitive landscape analysis, and key regions development ...
Breaking Biology Technology:Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... 25 DuPont (NYSE: DD ) and ... business agreements related to key plant biotechnology traits and ... the world. , , These agreements create ... and seed sales as well as royalties. The ...
... , , PALO ALTO, Calif., June 25 ... today announced it has acquired the assets of Houston-based ... the planning of radiotherapy and radiosurgery treatments. The acquisition ... software tool to automate and accelerate the most time-consuming ...
... U.S. Research Institute, Ceeker Correctly Detected Anthrax 100% of ... a Simple and Reliable Tool to Help Quickly Distinguish ... , --Study Data to be Presented by Prof. Lou ... and CHRISTCHURCH, New Zealand, June 25 Veritide Ltd., ...
Cached Biology Technology:DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 2DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 3DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 4Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning 2Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning 3Independent U.S. Study Confirms Veritide's Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability 2Independent U.S. Study Confirms Veritide's Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability 3Independent U.S. Study Confirms Veritide's Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability 4
... includes 1. Scanning of gel(s) 2. ... tryptic in-gel digestion and peptide extraction ... 5. Acquisition of PMF (Peptide Mass ... TOF/TOF) 6. Acquisition of PFF (Peptide ...
... The Vibratome Company has joined forces ... introduce the Vibratome 411301 Tissue Chopper. This ... prepare sections of tissue for metabolic experiments ... and irregular specimens available at biopsy or ...
... The ProteinChip Antibody Capture ... development and optimization steps ... antibody-antigen interactions. This kit ... differentiation of multiple antigens ...
Without sodium bicarbonate. Sterile, Cell culture tested...
Biology Products: